Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other

Tags
Inv. presentation
Quarterly results
Appointed director

CHAMPIONS ONCOLOGY, INC. (CSBR) Create: Alert

All | News | Filings
Date FiledTypeDescription
07/24/2023 10-K Annual Report for the period ended April 30, 2023
07/24/2023 8-K Quarterly results
04/05/2023 8-K Regulation FD Disclosure, Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "One University Plaza, Suite 307 Hackensack, NJ 07601 Tel: 551-206-8104 Champions Oncology Announces $5M Stock Repurchase Program"
03/16/2023 10-Q Quarterly Report for the period ended January 31, 2023
03/15/2023 8-K Quarterly results
Docs: "One University Plaza, Suite 307 Hackensack, NJ 07601 Tel: 551-206-8104 Champions Oncology Reports Quarterly Revenue of $12.8 Million"
12/13/2022 10-Q Quarterly Report for the period ended October 31, 2022
12/13/2022 8-K Quarterly results
10/20/2022 8-K Quarterly results
09/12/2022 10-Q Quarterly Report for the period ended July 31, 2022
09/08/2022 8-K Quarterly results
Docs: "One University Plaza, Suite 307 Hackensack, NJ 07601 Tel: 551-206-8104 Champions Oncology Reports Record Quarterly Revenue of $13.7 Million"
08/31/2022 DEF 14A Form DEF 14A - Other definitive proxy statements:
08/29/2022 DEF 14A Form DEF 14A - Other definitive proxy statements:
08/29/2022 DEFC14A Form DEFC14A - Definitive proxy statement, contested solicitations:
07/22/2022 10-K Annual Report for the period ended April 30, 2022
07/21/2022 8-K Quarterly results
03/15/2022 10-Q Quarterly Report for the period ended January 31, 2022
03/15/2022 8-K Quarterly results
Docs: "One University Plaza, Suite 307 Hackensack, NJ 07601 Tel: 551-206-8104 Champions Oncology Reports Record Quarterly Revenue of $13.2 Million Reported Adjusted EBITDA of $1.5 million"
02/14/2022 SC 13G/A West Elk Partners, LP reports a 8.1% stake in Champions Oncology, Inc.
12/13/2021 10-Q Quarterly Report for the period ended October 31, 2021
12/13/2021 8-K Quarterly results
10/21/2021 8-K Submission of Matters to a Vote of Security Holders  Interactive Data
09/13/2021 10-Q Quarterly Report for the period ended July 31, 2021
09/13/2021 8-K Quarterly results
09/01/2021 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
08/30/2021 DEF 14A Form DEF 14A - Other definitive proxy statements:
07/26/2021 10-K Annual Report for the period ended April 30, 2021
07/23/2021 SC 13G West Elk Partners, LP reports a 5.1% stake in Champions Oncology Inc.
07/22/2021 8-K Results of Operations and Financial Condition, Financial Statements and Exhibits  Interactive Data
Docs: "One University Plaza, Suite 307 Hackensack, NJ 07601 Champions Oncology Reports Quarterly Revenue of $10.6 Million Record Annual Revenue of $41 Million"
03/15/2021 10-Q Quarterly Report for the period ended January 31, 2021
03/11/2021 8-K Quarterly results
02/12/2021 8-K Quarterly results
12/14/2020 10-Q Quarterly Report for the period ended October 31, 2020
12/14/2020 8-K Results of Operations and Financial Condition, Financial Statements and Exhibits
Docs: "One University Plaza, Suite 307 Hackensack, NJ 07601 Tel: 551-206-8104 Champions Oncology Reports Record Quarterly Revenue of $10.1 Million"
10/21/2020 8-K Quarterly results
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy